Sucampo Pharmaceuticals, Inc. Separation Agreements
4 Contracts & Agreements
- Separation Agreement, dated as of June 6, 2017, between the Company and Matthias Alder (Filed With SEC on August 2, 2017)
- Separation Agreement, dated as of May 17, 2017, between the Company and Andrew Smith (Filed With SEC on August 2, 2017)
- SEPARATION AGREEMENT ANDRELEASES (Filed With SEC on May 5, 2016)
- SEPARATION AGREEMENT AND GENERAL RELEASE (Filed With SEC on July 28, 2008)
